Ultra-sensitive bioanalysis of the therapeutic peptide exenatide for accurate pharmacokinetic analyses at effective plasma concentrations utilizing UPLC-MS/MS

Exenatide is the first approved glucagon-like peptide 1 receptor agonist subcutaneously or intramuscularly injected for the treatment of type 2 diabetes mellitus. Typical therapeutic plasma concentrations are in the low pg/mL range, therefore requiring ultra-sensitive quantification. To enable the a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sauter, Max, Uhl, Philipp, Burhenne, Jürgen, Haefeli, Walter E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Xi'an Jiaotong University 2020
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7322758/
https://www.ncbi.nlm.nih.gov/pubmed/32612869
http://dx.doi.org/10.1016/j.jpha.2020.02.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7322758/
https://www.ncbi.nlm.nih.gov/pubmed/32612869
http://dx.doi.org/10.1016/j.jpha.2020.02.008

Ejemplares similares